Back to Search
Start Over
Urine levels of 5-aminoimidazole-4-carboxamide riboside (AICAR) in patients with type 2 diabetes.
- Source :
-
Acta diabetologica [Acta Diabetol] 2018 Jun; Vol. 55 (6), pp. 585-592. Date of Electronic Publication: 2018 Mar 15. - Publication Year :
- 2018
-
Abstract
- Aims: 5-Aminoimidazole-4-carboxamide riboside (AICAR) is an endogenous activator of AMPK, a central regulator of energy homeostasis. Loss and/or reduction of AMPK signaling plays an important role in the development of insulin resistance in type 2 diabetes. The loss of AMPK in diabetes could be due to a loss of AICAR. The aim of this study was to characterize urine levels of AICAR in diabetes and determine whether an association exists with respect to late complications, e.g., retinopathy, nephropathy and neuropathy.<br />Methods: Urine AICAR was measured by liquid chromatography tandem mass spectrometry in 223 patients consisting of 5 healthy controls, 63 patients with pre-diabetes, 29 patients with newly diagnosed type 2 diabetes and 126 patients with long-standing type 2 diabetes. For statistical analyses, nonparametric Kruskal-Wallis test, one-way ANOVA and multivariate regression analysis were performed to investigate the associations of urinary AICAR excretion within different groups and different clinical parameters.<br />Results: The mean urine AICAR for all 223 patients was 694.7 ± 641.1 ng/ml. There was no significant difference in urine AICAR between the control and patients with diabetes (592.3 ± 345.1 vs. 697.1 ± 646.5 ng/ml). No association between any of the biochemical and/or clinical parameters measured and urine AICAR was found, with the exception of age of patient (R = - 0.34; p < 0.01) and estimated glomerular filtration rate (R = 0.19; p = 0.039). These results were confirmed additionally by linear regression analysis.<br />Conclusions: Clinical diabetes is not associated with a change in endogenous AICAR levels. Loss of AICAR may therefore not be a mechanism by which AMPK signaling is reduced in diabetes.
- Subjects :
- Adenylate Kinase metabolism
Adult
Aged
Aminoimidazole Carboxamide urine
Animals
Case-Control Studies
Cohort Studies
Diabetes Complications metabolism
Diabetes Complications prevention & control
Diabetes Complications urine
Diabetes Mellitus, Type 2 complications
Diabetes Mellitus, Type 2 metabolism
Diabetes Mellitus, Type 2 prevention & control
Female
Humans
Male
Middle Aged
Prediabetic State pathology
Prediabetic State therapy
Prediabetic State urine
Risk Factors
Risk Reduction Behavior
Signal Transduction physiology
Aminoimidazole Carboxamide analogs & derivatives
Diabetes Mellitus, Type 2 urine
Ribonucleotides urine
Subjects
Details
- Language :
- English
- ISSN :
- 1432-5233
- Volume :
- 55
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Acta diabetologica
- Publication Type :
- Academic Journal
- Accession number :
- 29546577
- Full Text :
- https://doi.org/10.1007/s00592-018-1130-2